pdufa.bio
CalendarReadoutsDevicesDecisionsApprovals/yrTrial oddsLearnResearchMethodology
Home › 2026 Clinical Trial Readout Calendar

2026 Clinical Trial Readout Calendar

Upcoming Phase 1/2/3 data readouts — company, drug, indication, and the registered trial. Dates are estimated primary-completion windows from ClinicalTrials.gov, not fixed announcements — they shift. Tap any row for the trial record.
PDUFA datesTrial readoutsDevices
14Jun '2633Jul40Aug47Sep41Oct31Nov103Dec36Jan '2722Feb45Mar27Apr26May48Jun21Jul41Aug33Sep26Oct21Nov42Dec
Upcoming readouts per month (dated estimates; quarter/half-year-only items not charted).
June 2026
WVE · Jun 2026 (est.)
WVE-210201 — Duchenne Muscular Dystrophy
LEGN · Jun 2026 (est.)
LCAR-B38M CAR-T Cell — B-Cell Non-Hodgkin Lymphoma-Recurrent
JAZZ · Jun 2026 (est.)
Zanidatamab — Gastroesophageal Adenocarcinoma
CLLS · Jun 2026 (est.)
UCART22 — B-cell Acute Lymphoblastic Leukemia
CMPS · Jun 2026 (est.)
COMP360 psilocybin — Major Depressive Disorder
CELC · Jun 2026 (est.)
Gedatolisib — Breast Cancer
BMY · Jun 2026 (est.)
Nivolumab — Metastatic Renal Cell Carcinoma
OLMA · Jun 2026 (est.)
Palazestrant — Breast Cancer
TRVI · Jun 2026 (est.)
Nalbuphine ER Tablets — Idiopathic Pulmonary Fibrosis
ARDX · Jun 2026 (est.)
Tenapanor — Cystic Fibrosis
AGIO · Jun 2026 (est.)
Mitapivat — Anemia
ZBIO · Jun 2026 (est.)
Orelabrutinib — Warm Autoimmune Hemolytic Anemia
TLX · Jun 2026 (est.)
177Lu-TLX591 — Clear Cell Renal Cell Carcinoma
PTCT · Jun 2026 (est.)
PTC923 — Phenylketonuria
July 2026
JAZZ · Jul 2026 (est.)
Lurbinectedin — Advanced Soft-tissue Sarcoma
IOVA · Jul 2026 (est.)
Lifileucel plus Pembrolizumab — Soft Tissue Sarcoma
HOWL · Jul 2026 (est.)
WTX-330 — Metastatic Solid Tumor
LXRX · Jul 2026 (est.)
Sotagliflozin — Obstructive Cardiomyopathy, Hypertrophic
EXEL · Jul 2026 (est.)
Cabozantinib — Non-Small Cell Lung Cancer
EVMN · Jul 2026 (est.)
EVO756 — Atoptic Dermatitis
ELVN · Jul 2026 (est.)
ELVN-002 — HER2 Mutant Non-small Cell Lung Cancer
DWTX · Jul 2026 (est.)
Halneuron — Chemotherapy Induced Neuropathic Pain
DFTX · Jul 2026 (est.)
DT120 — Generalized Anxiety Disorder
CRDF · Jul 2026 (est.)
Onvansertib — Pancreatic Cancer
AKBA · Jul 2026 (est.)
Vadadustat — Nonintubated Acute Respiratory Distress Syndrome (ARDS)
ANIP · Jul 2026 (est.)
Yutiq — Uveitis
ARDX · Jul 2026 (est.)
Tenapanor — Irritable Bowel Syndrome With Constipation (IBS-C)
AXSM · Jul 2026 (est.)
AXS-14 — Major Depressive Disorder (MDD)
ALMS · Jul 2026 (est.)
Open-Label Envudeucitinib — SLE
SNGX · Jul 2026 (est.)
Hypericin — CTCL/ Mycosis Fungoides
SMMT · Jul 2026 (est.)
Ivonescimab — Salivary Gland Cancer
SION · Jul 2026 (est.)
SION-719 — Cystic Fibrosis (CF)
RARE · Jul 2026 (est.)
GTX-102 — Angelman Syndrome
PYXS · Jul 2026 (est.)
PYX-201 — Solid Tumor
PHVS · Jul 2026 (est.)
deucrictibant — Intradialytic Hypotension
CALC · Jul 2026 (est.)
CM4620 — Acute Kidney Injury
TTRX · Jul 2026 (est.)
GX-03 — Eczema Atopic Dermatitis
AMGN · Jul 2026 (est.)
Tezepelumab — Eosinophilic Esophagitis
CANF · Jul 2026 (est.)
Namodenoson — Pancreatic Adenocarcinoma
HCWB · Jul 2026 (est.)
Carboplatin AUC 5 and paclitaxel — Alopecia Areata(AA)
LTRN · Jul 2026 (est.)
Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel — Advanced Solid Tumor
ILMN · Jul 2026 (est.)
18F-MFBG — Neuroblastoma
QNRX · Jul 2026 (est.)
QRX003 — Netherton Syndrome
JAZZ · Jul 2026 (est.)
Tislelizumab — Gastric Neoplasms
OCGN · Jul 2026 (est.)
OCU410ST — Center Involved Diabetic Macular Edema
PSNL · Jul 2026 (est.)
Pembrolizumab — Adenocarcinoma of the Colon
CERS · Jul 2026 (est.)
S-303 Treated Red Blood Cells — Anemia
August 2026
IVVD · Aug 2026 (est.)
VYD2311 — COVID-19
GPCR · Aug 2026 (est.)
aleniglipron — Obesity, Overweight, or Chronic Weight Management
GRFS · Aug 2026 (est.)
ALPHA-1 MP — Pulmonary Emphysema in Alpha-1 PI Deficiency
HELP · Aug 2026 (est.)
CYB003 — Major Depressive Disorder
IGC · Aug 2026 (est.)
IGC-AD1-Active — Alzheimer Disease
KOD · Aug 2026 (est.)
Tarcocimab Tedromer — Wet Age-related Macular Degeneration
KPTI · Aug 2026 (est.)
Selinexor — Endometrial Cancer
KURA · Aug 2026 (est.)
Ziftomenib — AML
KYTX · Aug 2026 (est.)
Standard of Care Treatment — Lupus Nephritis
MANE · Aug 2026 (est.)
VDPHL01 — Androgenetic Alopecia
CADL · Aug 2026 (est.)
Aglatimagene Besadenovec — Prostate Cancer Patients Treated by Radiotherapy
CORT · Aug 2026 (est.)
Relacorilant — Ovarian Cancer
CRIS · Aug 2026 (est.)
chondrocyte-alginate gel suspension — Relapsed Hematologic Malignancy
DFTX · Aug 2026 (est.)
DT120 — Generalized Anxiety Disorder
ENSC · Aug 2026 (est.)
PF614 capsule — Postoperative Pain, Acute
EYPT · Aug 2026 (est.)
EYP-1901 — Wet Age Related Macular Degeneration
MIRM · Aug 2026 (est.)
Brelovitug — Chronic Hepatitis D Infection
MPLT · Aug 2026 (est.)
ML-007C-MA — Schizophrenia
ACRS · Aug 2026 (est.)
A-101 — Atopic Dermatitis
XENE · Aug 2026 (est.)
Azetukalner — Major Depressive Disorder
NCNA · Aug 2026 (est.)
NUC-1031 — Advanced Cancer
NVO · Aug 2026 (est.)
Semaglutide — NAFLD
PHVS · Aug 2026 (est.)
deucrictibant — Hereditary Angioedema (HAE)
RGNX · Aug 2026 (est.)
Ranibizumab — Neovascular Age-Related Macular Degeneration (nAMD)
RIGL · Aug 2026 (est.)
Fostamatinib Disodium — Low Risk Myelodysplastic Syndromes
TMO · Aug 2026 (est.)
MK-7240 — Ulcerative Colitis
BMRN · Aug 2026 (est.)
Vosoritide — Hypochondroplasia
BIVI · Aug 2026 (est.)
NE3107 — Long COVID
AKBA · Aug 2026 (est.)
Vadadustat — Anemia of Chronic Kidney Disease
ANRO · Aug 2026 (est.)
ALTO-100 — Bipolar Disorder I or II With a Major Depressive Episode
MRK · Aug 2026 (est.)
Ensifentrine — Chronic Obstructive Pulmonary Disease
INCY · Aug 2026 (est.)
Ruxolitinib — NonSegmental Vitiligo
ACRV · Aug 2026 (est.)
ACR-368 — Specific Advanced Solid Tumors
JSPR · Aug 2026 (est.)
Briquilimab — Urticaria Chronic
TMO · Aug 2026 (est.)
Nexium — Erosive Esophagitis
PMVP · Aug 2026 (est.)
rezatapopt — Advanced Solid Tumor
CLRB · Aug 2026 (est.)
NOV-002 — Pediatric Solid Tumor
MSLE · Aug 2026 (est.)
SAT-3247 — Duchenne Muscular Dystrophy (DMD)
VSTM · Aug 2026 (est.)
avutometinib — KRAS Activating Mutation
NRIX · Aug 2026 (est.)
NX-5948 — Ovarian Cancer, Epithelial
September 2026
AVIR · Sep 2026 (est.)
Bemnifosbuvir-Ruzasvir — HEPATITIS C VIRUS CHRONIC INFECTION
ARVN · Sep 2026 (est.)
ARV-471 — Breast Cancer
ARQT · Sep 2026 (est.)
Topical Roflumilast — Hidradenitis Suppurativa
ARDX · Sep 2026 (est.)
Tenapanor — Irritable Bowel Syndrome With Constipation (IBS-C)
GKOS · Sep 2026 (est.)
GLK-321 — Demodex Blepharitis
GILD · Sep 2026 (est.)
Sacituzumab Govitecan — Non-small Cell Lung Cancer
EXEL · Sep 2026 (est.)
Cabozantinib — RCC
DSGN · Sep 2026 (est.)
DT-168 — Fuchs Endothelial Corneal Dystrophy
CORT · Sep 2026 (est.)
Relacorilant — Nonalcoholic Steatohepatitis (NASH)
CGEM · Sep 2026 (est.)
CLN-081 — Multiple Myeloma
BHVN · Sep 2026 (est.)
Taldefgrobep Alfa — Obesity
LEGN · Sep 2026 (est.)
LCAR-B38M CAR-T Cell — Relapsed B-cell Non-Hodgkin Lymphoma
KPTI · Sep 2026 (est.)
Selinexor — Myelofibrosis
IRON · Sep 2026 (est.)
DISC-1459 — Erythropoietic Protoporphyria (EPP)
IOVA · Sep 2026 (est.)
Lifileucel plus Pembrolizumab — Gastric Cancer
APGE · Sep 2026 (est.)
APG777 — Asthma
GPCR · Sep 2026 (est.)
aleniglipron — Obese
VERA · Sep 2026 (est.)
Atacicept — IgA Nephropathy (IgAN)
VNDA · Sep 2026 (est.)
VSJ-110 — Dry Eye
TYRA · Sep 2026 (est.)
TYRA-300 — Locally Advanced Cholangiocarcinoma
SUPN · Sep 2026 (est.)
SPN-812 — Attention-Deficit/Hyperactivity Disorder
SNDX · Sep 2026 (est.)
Revumenib — Idiopathic Pulmonary Fibrosis
SLN · Sep 2026 (est.)
SLN124 — Polycythemia Vera
AGMB · Sep 2026 (est.)
AGMB-129 — Fibrostenotic Crohn's Disease
WVE · Sep 2026 (est.)
WVE-210201 — Alpha-1 Antitrypsin Deficiency
VTVT · Sep 2026 (est.)
Cadisegliatin — Diabetes Mellitus, Type 1
RAPP · Sep 2026 (est.)
RAP-219 — Bipolar 1 Disorder
MAZE · Sep 2026 (est.)
MZE829 — Proteinuric Kidney Disease
PCSA · Sep 2026 (est.)
PCS6422 and capecitabine — Breast Cancer
MRK · Sep 2026 (est.)
Pembrolizumab — Metastatic Triple-Negative Breast Cancer
NVCR · Sep 2026 (est.)
Temozolomide — Anaplastic (Malignant) Meningioma
ORIC · Sep 2026 (est.)
ORIC-114 — Solid Tumors
BMY · Sep 2026 (est.)
Bevacizumab — Advanced Solid Tumors
CORT · Sep 2026 (est.)
Relacorilant — Treatment-resistant PTSD
CRDL · Sep 2026 (est.)
CardiolRx — Recurrent Pericarditis
VIR · Sep 2026 (est.)
VIR-2218 — Hepatic Impairment
BIIB · Sep 2026 (est.)
Litifilimab — Lupus Erythematosus, Systemic
MLTX · Sep 2026 (est.)
Sonelokimab — Hidradenitis Suppurativa
OCGN · Sep 2026 (est.)
OCU410ST — Stargardt Disease
ILMN · Sep 2026 (est.)
18F-MFBG — Parkinson Disease (PD)
IBRX · Sep 2026 (est.)
ALT-803 — Non-muscle Invasive Bladder Cancer
ALEC · Sep 2026 (est.)
AL001 — Alzheimer's Disease
EXEL · Sep 2026 (est.)
Cabozantinib — High Grade Neuroendocrine Neoplasms
CHRS · Sep 2026 (est.)
CHS-1420 — Advanced Solid Tumor
CCCC · Sep 2026 (est.)
Cemsidomide — Multiple Myeloma
BIIB · Sep 2026 (est.)
Litifilimab — Lupus Erythematosus, Systemic
IMMP · Sep 2026 (est.)
eftilagimod alfa — Solid Tumors
October 2026
OGN · Oct 2026 (est.)
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5 — Plaque Psoriasis
PFE · Oct 2026 (est.)
Palbociclib — Metastatic Renal Cell Carcinoma
RGNX · Oct 2026 (est.)
Ranibizumab — AMD
SNDX · Oct 2026 (est.)
Revumenib — Refractory Acute Myeloid Leukemia
TENX · Oct 2026 (est.)
TNX-103 — Pulmonary Hypertension
XENE · Oct 2026 (est.)
Azetukalner — Focal Onset Seizures
ABOS · Oct 2026 (est.)
sabirnetug — Alzheimer Disease
AGEN · Oct 2026 (est.)
Balstilimab — Anatomic Stage IV Breast Cancer AJCC v8
ARWR · Oct 2026 (est.)
Plozasiran — Obesity
MIRM · Oct 2026 (est.)
Maralixibat — Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
CLDX · Oct 2026 (est.)
Barzolvolimab — Chronic Spontaneous Urticaria
COCP · Oct 2026 (est.)
CDI-988 — Norovirus
CORT · Oct 2026 (est.)
Relacorilant — Amyotrophic Lateral Sclerosis
CRNX · Oct 2026 (est.)
Atumelnant — Cushing Syndrome
EYPT · Oct 2026 (est.)
EYP-1901 — Wet Age Related Macular Degeneration
HUMA · Oct 2026 (est.)
Human Acellular Vessel — End Stage Renal Disease (ESRD)
IMVT · Oct 2026 (est.)
IMVT-1402 — Subacute Cutaneous Lupus Erythematosus
IOVA · Oct 2026 (est.)
Lifileucel plus Pembrolizumab — HPV-Associated Cervical Carcinoma
IRON · Oct 2026 (est.)
DISC-1459 — Inflammatory Bowel Disease (IBD)
PSTV · Oct 2026 (est.)
Rhenium Liposome Treatment — Leptomeningeal Metastasis
TECX · Oct 2026 (est.)
TX000045- Dose A — Pulmonary Hypertension
SLDB · Oct 2026 (est.)
SGT-003 — Duchenne Muscular Dystrophy
INCY · Oct 2026 (est.)
Povorcitinib — Prurigo Nodularis
BIIB · Oct 2026 (est.)
Litifilimab — Subacute Cutaneous Lupus Erythematosus
CSLLY · Oct 2026 (est.)
Recombinant Single-Chain Factor Viii — Congenital Hemophilia A
ADCT · Oct 2026 (est.)
Loncastuximab Tesirine — B-Cell Non-Hodgkin Lymphoma
SNY · Oct 2026 (est.)
Venglustat — Gaucher Disease Type 1
MRK · Oct 2026 (est.)
Pembrolizumab — Metastatic Uveal Melanoma
ILMN · Oct 2026 (est.)
18F-MFBG — Heart Failure
INBX · Oct 2026 (est.)
INBRX-106 — Solid Tumor
MBX · Oct 2026 (est.)
MBX 2109 — Obesity
VTRS · Oct 2026 (est.)
Cenerimod — Lupus Erythematosus, Systemic
JSPR · Oct 2026 (est.)
Briquilimab — Chronic Spontaneous Urticaria
MRK · Oct 2026 (est.)
IMG-7289 — Essential Thrombocythemia
RCUS · Oct 2026 (est.)
Zimberelimab — Non Small Cell Lung Cancer
RYTM · Oct 2026 (est.)
Setmelanotide — Prader-Willi Syndrome
SRPT · Oct 2026 (est.)
Eteplirsen — Muscular Dystrophy, Duchenne
SYRE · Oct 2026 (est.)
SPY001 — Rheumatoid Arthritis
ADAG · Oct 2026 (est.)
Pembrolizumab — Advanced/Metastatic Solid Tumors
ANNX · Oct 2026 (est.)
Tanruprubart — Geographic Atrophy
IMMP · Oct 2026 (est.)
eftilagimod alfa — Breast Carcinoma
November 2026
ATOS · Nov 2026 (est.)
Z-Endoxifen — Breast Neoplasms
APGE · Nov 2026 (est.)
APG777 — Atopic Dermatitis
TLX · Nov 2026 (est.)
177Lu-TLX591 — Prostate Adenocarcinoma
ERAS · Nov 2026 (est.)
Naporafenib — Advanced or Metastatic Solid Tumors
GILD · Nov 2026 (est.)
Sacituzumab Govitecan — Esophageal Squamous Cell Carcinoma
IMUX · Nov 2026 (est.)
IMU-838 tablets — Multiple Sclerosis
IOVA · Nov 2026 (est.)
Lifileucel plus Pembrolizumab — Metastatic Melanoma
KPRX · Nov 2026 (est.)
KIO-104 — Macular Edema
ONC · Nov 2026 (est.)
BGB-11417 — Relapsed/Refractory Multiple Myeloma
ANL · Nov 2026 (est.)
Buparlisib & Paclitaxel — Advanced Solid Tumor
TRAW · Nov 2026 (est.)
rigosertib — Influenza
TYRA · Nov 2026 (est.)
TYRA-300 — Locally Advanced Urothelial Carcinoma
VIR · Nov 2026 (est.)
Bulevirtide — Viral Hepatitis
VXRT · Nov 2026 (est.)
VXA-COV2-3.3 — SARS-CoV2
ZURA · Nov 2026 (est.)
Tibulizumab — Hidradenitis Suppurativa (HS)
ELTX · Nov 2026 (est.)
ELI-002 7P — Pancreatic Ductal Adenocarcinoma
DRUG · Nov 2026 (est.)
BMB-101 — Prader-Willi Syndrome
CRDF · Nov 2026 (est.)
Onvansertib — Metastatic Colorectal Cancer
BHVN · Nov 2026 (est.)
BHV-7000 — Familial Erythromelalgia
BYSI · Nov 2026 (est.)
Docetaxel + Plinabulin — Multiple Myeloma
CGEM · Nov 2026 (est.)
CLN-081 — NHL
EVO · Nov 2026 (est.)
JST-018 — Antiviral Drug
PGEN · Nov 2026 (est.)
PRGN-2009 — Cervical Cancer
ACHV · Nov 2026 (est.)
Custirsen — Vaping Cessation
SKYE · Nov 2026 (est.)
SBI-100 Ophthalmic Emulsion, — Obesity
AURA · Nov 2026 (est.)
Bel-sar — Eye Cancer
BIOA · Nov 2026 (est.)
BGE-102 — Obesity and Cardiovascular Risk
PHAR · Nov 2026 (est.)
Leniolisib — APDS
QURE · Nov 2026 (est.)
AMT-260 — Mesial Temporal Lobe Epilepsy
RNAC · Nov 2026 (est.)
Decartes-08 — Myasthaenia Gravis
SNY · Nov 2026 (est.)
Rilzabrutinib — Immune Thrombocytopenia
December 2026
EXEL · Dec 2026 (est.)
Cabozantinib — Metastatic Renal Cell Carcinoma
CNTA · Dec 2026 (est.)
cleminorexton — Narcolepsy Type 1
BEAM · Dec 2026 (est.)
BEAM-302 — Lymphoblastic Lymphoma
BIIB · Dec 2026 (est.)
Felzartamab — Antibody-mediated Rejection
BMY · Dec 2026 (est.)
Nivolumab — Non Small Cell Lung Cancer
BRTX · Dec 2026 (est.)
BRTX-100 — Lumbar Disc Disease
CGEM · Dec 2026 (est.)
CLN-081 — SLE
CMPX · Dec 2026 (est.)
CTX-009 — Biliary Tract Cancer
CNTX · Dec 2026 (est.)
Onapristone ER — Mesothelin-Expressing Tumors
CORT · Dec 2026 (est.)
Relacorilant — Cushing Syndrome
DCTH · Dec 2026 (est.)
Cisplatin and Gemcitabine — Refractory Metastatic Colorectal Cancer
DMAC · Dec 2026 (est.)
Recombinant human tissue kallikrein — Acute Stroke
DSGN · Dec 2026 (est.)
DT-168 — Friedreich Ataxia
EIKN · Dec 2026 (est.)
EIK1001 — Solid Tumor, Adult
ENTA · Dec 2026 (est.)
Zelicapavir — RSV Infection
BCDA · Dec 2026 (est.)
Autologous cell therapy — Heart Failure, Systolic
EPRX · Dec 2026 (est.)
EP-104GI — Eosinophilic Esophagitis
BHVN · Dec 2026 (est.)
BHV-7000 — Focal Epilepsy
ABVX · Dec 2026 (est.)
ABX464 — Moderately to Severely Active Crohn Disease
AGEN · Dec 2026 (est.)
Balstilimab — Refractory Metastatic Colorectal Cancer
ALMS · Dec 2026 (est.)
Open-Label Envudeucitinib — Plaque Psoriasis
ALZN · Dec 2026 (est.)
AL001 — Bipolar I Disorder
ANRO · Dec 2026 (est.)
ALTO-300 — Major Depressive Disorder
APGE · Dec 2026 (est.)
APG777 — Atopic Dermatitis
ARDX · Dec 2026 (est.)
Tenapanor — Synucleinopathy
ARWR · Dec 2026 (est.)
Plozasiran — Myotonic Dystrophy 1
AVIR · Dec 2026 (est.)
Bemnifosbuvir-Ruzasvir — HEPATITIS C VIRUS CHRONIC INFECTION
AVLN · Dec 2026 (est.)
AP01 — Idiopathic Pulmonary Fibrosis (IPF)
ADCT · Dec 2026 (est.)
Loncastuximab Tesirine — Diffuse Large B-Cell Lymphoma
AXSM · Dec 2026 (est.)
AXS-14 — Excessive Sleepiness
MDGL · Dec 2026 (est.)
Resmetirom — NASH
MNPR · Dec 2026 (est.)
Clonidine HCl Mucoadhesive Buccal Tablet — Solid Tumor, Adult
MRK · Dec 2026 (est.)
Pembrolizumab — Squamous Cell Cancer of Head and Neck
NKTX · Dec 2026 (est.)
NKX019 — Systemic Lupus Erythematosus
ONC · Dec 2026 (est.)
Zanubrutinib — Waldenstrom Macroglobulinemia
ORIC · Dec 2026 (est.)
ORIC-114 — Solid Tumors
PBYI · Dec 2026 (est.)
neratinib — Breast Cancer
PFE · Dec 2026 (est.)
Elranatamab — Multiple Myeloma
PHAT · Dec 2026 (est.)
Vonoprazan — Eosinophilic Esophagitis
RANI · Dec 2026 (est.)
PG-102 — Obesity
RCUS · Dec 2026 (est.)
Quemliclustat — Borderline Resectable Pancreatic Adenocarcinoma
RGNX · Dec 2026 (est.)
Ranibizumab — AMD
RNAC · Dec 2026 (est.)
Decartes-08 — Systemic Lupus Erythematosus (SLE)
MDWD · Dec 2026 (est.)
EscharEx — Venous Leg Ulcer (VLU)
MANE · Dec 2026 (est.)
VDPHL01 — Androgenetic Alopecia
LXEO · Dec 2026 (est.)
LX1001 — Arrhythmogenic Cardiomyopathy
GLSI · Dec 2026 (est.)
GLSI-100 — Breast Cancer
GNLX · Dec 2026 (est.)
olvimulogene nanivacirepvec — SCLC, Extensive Stage
GOSS · Dec 2026 (est.)
Seralutinib — Pulmonary Arterial Hypertension
IMMX · Dec 2026 (est.)
NXC-201 CAR-T — Light Chain (AL) Amyloidosis
INO · Dec 2026 (est.)
VGX-3100 — BRCA1/2 Mutation
IONS · Dec 2026 (est.)
Donidalorsen — Hereditary Angioedema
IXHL · Dec 2026 (est.)
IHL-42X Low Dose — Obstructive Sleep Apnea
JAZZ · Dec 2026 (est.)
CPX-351 — Acute Myeloid Leukemia (AML) in Remission
KPTI · Dec 2026 (est.)
Rituximab — Relapsed/Refractory Diffuse Large B-cell Lymphoma
KRYS · Dec 2026 (est.)
KB803 — Dystrophic Epidermolysis Bullosa
KZIA · Dec 2026 (est.)
GDC-0084 — Primary Central Nervous System Lymphoma
LTRN · Dec 2026 (est.)
Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel — Adenocarcinoma of Lung
SMMT · Dec 2026 (est.)
Ivonescimab — Stomach Cancer Stage IV
TVTX · Dec 2026 (est.)
Pegtibatinase — Proteinuric Renal Disease
VNDA · Dec 2026 (est.)
VQW-765 — Social Anxiety Disorder (SAD)
UTHR · Dec 2026 (est.)
Ralinepag — PAH
TRAW · Dec 2026 (est.)
rigosertib — Influenza
VIR · Dec 2026 (est.)
Tobevibart — Viral Hepatitis
TARA · Dec 2026 (est.)
Choline Chloride for Injection — Lymphatic Malformation
SNDX · Dec 2026 (est.)
Revumenib — Leukemia
ABUS · Dec 2026 (est.)
AB-729 — Chronic Hepatitis B
ZNTL · Dec 2026 (est.)
Investigator's choice of Chemotherapy — High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
XNCR · Dec 2026 (est.)
XMAB20717 — Biliary Tract Cancer
PFE · Dec 2026 (est.)
Mevrometostat — Metastatic Castration-Resistant Prostate Cancer
CRDF · Dec 2026 (est.)
Onvansertib — Breast Cancer
ENSC · Dec 2026 (est.)
PF614 capsule — Pharmacokinetics
SNY · Dec 2026 (est.)
Rilzabrutinib — Focal Segmental Glomerulosclerosis
BPTH · Dec 2026 (est.)
BP1001 in combination with Ventoclax plus decitabine — Poliomyelitis
KARD · Dec 2026 (est.)
danicamtiv — Hypertension
ICLR · Dec 2026 (est.)
HT-001 — Acneiform Eruption Due to Chemical
SNDX · Dec 2026 (est.)
Revumenib — Acute Myeloid Leukemia
SUPN · Dec 2026 (est.)
BIS-001 — Focal Impaired Awareness Seizures
ARVN · Dec 2026 (est.)
ARV-471 — Breast Cancer
MNOV · Dec 2026 (est.)
MN-166 — Diabetes Mellitus, Type 2
PBYI · Dec 2026 (est.)
neratinib — Lung Cancer Metastatic
PFE · Dec 2026 (est.)
Palbociclib — Breast Cancer
PLYX · Dec 2026 (est.)
PLX-200 — Juvenile Neuronal Ceroid Lipofuscinosis
SYK · Dec 2026 (est.)
Ropivacaine — Sarcoma
TARS · Dec 2026 (est.)
TP-03 — Ocular Rosacea
VIR · Dec 2026 (est.)
Tobevibart — Viral Hepatitis
ACAD · Dec 2026 (est.)
ACP-204 — Autism Spectrum Disorder
ACTU · Dec 2026 (est.)
Losartan — Pancreatic Adenocarcinoma
ADAG · Dec 2026 (est.)
Pembrolizumab — Advanced Solid Tumor
ADCT · Dec 2026 (est.)
Loncastuximab Tesirine — Chronic Lymphocytic Leukemia
ANNX · Dec 2026 (est.)
Tanruprubart — Guillain-Barre Syndrome
ARVN · Dec 2026 (est.)
ARV-471 — Breast Cancer
NVO · Dec 2026 (est.)
Semaglutide — Intestinal Mucositis
JAZZ · Dec 2026 (est.)
Zanidatamab — Breast Cancer
INSM · Dec 2026 (est.)
Treprostinil Palmitil Inhalation Powder — Pulmonary Arterial Hypertension
BCAX · Dec 2026 (est.)
Ficerafusp alfa — Head and Neck Squamous Cell Carcinoma
CERO · Dec 2026 (est.)
CER-1236 — AML
CLDX · Dec 2026 (est.)
Barzolvolimab — Breast Cancer
CMND · Dec 2026 (est.)
CMND-100 — Alcohol Use Disorder
ESLA · Dec 2026 (est.)
EB103 — B-Cell Non-Hodgkin's Lymphoma (NHL)
EXEL · Dec 2026 (est.)
XL-092 — Hepatocellular Carcinoma
FBRX · Dec 2026 (est.)
FB102 — Vitiligo
INO · Dec 2026 (est.)
VGX-3100 — Glioblastoma
H1 2026 (est.)
AMLX · H1 2026
AMX0035 — Progressive Supranuclear Palsy
TVRD · H1 2026
TTI-101 — Hepatocellular Carcinoma
NBP · H1 2026
TJ003234 — Coronavirus Disease 2019 COVID-19
CGON · H1 2026
Cretostimogene Grenadenorepvec — Non Muscle Invasive Bladder Cancer
H2 2026 (est.)
QTTB · H2 2026
bempikibart — Alopecia Areata
FDMT · H2 2026
4D-150 IVT — Macular Neovascularization Secondary to Age-Related Macular Degeneration
NTLA · H2 2026
NTLA-2002 — Hereditary Angioedema
PCVX · H2 2026
31-valent pneumococcal conjugate vaccine — Pneumococcal Vaccines
PHVS · H2 2026
deucrictibant — Hereditary Angioedema
SION · H2 2026
SION-719 — Cystic Fibrosis (CF)
ZNTL · H2 2026
Investigator's choice of Chemotherapy — Ovarian Cancer
AURA · H2 2026
Bel-sar — Choroidal Melanoma
SABS · H2 2026
SAB-142
KPTI · H2 2026
EX-99
ANRO · H2 2026
EX-99
VRDN · H2 2026
VRDN-008
ADCT · H2 2026
rituximab
NGNE · H2 2026
NGN-401
Q2 2026 (est.)
ANNX · Q2 2026
Tanruprubart — Guillain-Barre Syndrome
MIRM · Q2 2026
Brelovitug
Q3 2026 (est.)
ALMS · Q3 2026
Open-Label Envudeucitinib — Plaque Psoriasis
ZURA · Q3 2026
Tibulizumab — Systemic Sclerosis (SSc)
AMLX · Q3 2026
AMX0035 — Progressive Supranuclear Palsy
Q4 2026 (est.)
CLDX · Q4 2026
Barzolvolimab — Chronic Inducible Urticaria
RGNX · Q4 2026
Ranibizumab — AMD
IRON · Q4 2026
DISC-1459 — Erythropoietic Protoporphyria
HELP · Q4 2026
CYB003 — Major Depressive Disorder
ATAI · Q4 2026
BPL-003
January 2027
CGEM · Jan 2027 (est.)
CLN-081 — Relapsed/Refractory Acute Myeloid Leukemia (AML)
COYA · Jan 2027 (est.)
COYA 302 — Amyotrophic Lateral Sclerosis (ALS)
ELDN · Jan 2027 (est.)
Islet transplantation with Tegoprubart (AT-1501) immunosupression-based therapy — Prevention of Rejection in Kidney Transplant
ELVN · Jan 2027 (est.)
ELVN-002 — HER2-positive Breast Cancer
EXEL · Jan 2027 (est.)
Cabozantinib — Germ Cell Tumor
INAB · Jan 2027 (est.)
Autologous genetically modified gamma-delta T cells — Acute Myeloid Leukemia
IOVA · Jan 2027 (est.)
Lifileucel plus Pembrolizumab — Cervical Cancer
KURA · Jan 2027 (est.)
Ziftomenib — Solid Tumors With HRAS Alterations
KYTX · Jan 2027 (est.)
Standard of Care Treatment — ANCA-IgG-positive ANCA Associated Vasculitis
LRMR · Jan 2027 (est.)
CTI-1601 — Friedreich Ataxia
NRIX · Jan 2027 (est.)
NX-5948 — Chronic Lymphocytic Leukemia (CLL)
NUVL · Jan 2027 (est.)
Neladalkib — Locally Advanced Solid Tumor
PCVX · Jan 2027 (est.)
31-valent pneumococcal conjugate vaccine — Pneumococcal Vaccines
RARE · Jan 2027 (est.)
Setrusumab — Osteogenesis Imperfecta
SGMT · Jan 2027 (est.)
Denifanstat — Acne
SIGA · Jan 2027 (est.)
Tecovirimat Oral Capsule — Smallpox
XENE · Jan 2027 (est.)
Azetukalner — Major Depressive Disorder
ZVRA · Jan 2027 (est.)
KP415 oral capsule — Medium-chain Acyl-CoA Dehydrogenase Deficiency
ACAD · Jan 2027 (est.)
ACP-204 — Intermittent Explosive Disorder
CALC · Jan 2027 (est.)
CM4620 — Acute Pancreatitis
CADL · Jan 2027 (est.)
Aglatimagene Besadenovec — Malignant Glioma of Brain
BMY · Jan 2027 (est.)
Nivolumab — Hodgkin Lymphoma
REGN · Jan 2027 (est.)
Odronextamab — Follicular Lymphoma
OCUL · Jan 2027 (est.)
Otx-Tki — Neovascular Age-related Macular Degeneration
GILD · Jan 2027 (est.)
MK-3475 — Carcinoma, Non-Small-Cell Lung
AZTR · Jan 2027 (est.)
ATR04-484 — EGFR Inhibitor-associated Rash
IDYA · Jan 2027 (est.)
Darovasertib — Metastatic Uveal Melanoma
MLTX · Jan 2027 (est.)
Sonelokimab — Arthritis, Psoriatic
XBIT · Jan 2027 (est.)
Methotrexate — Rheumatoid Arthritis
CRBP · Jan 2027 (est.)
CRB-701 — Solid Tumor, Adult
SGMT · Jan 2027 (est.)
Denifanstat — Prostatic Neoplasms, Castration-Resistant
IDYA · Jan 2027 (est.)
IDE196 — Metastatic Uveal Melanoma
QNRX · Jan 2027 (est.)
QRX003 — Netherton Syndrome
CELZ · Jan 2027 (est.)
CELZ-201 Administration — Type 1 Diabetes
CUE · Jan 2027 (est.)
CUE-101 — Recurrent Glioblastoma
APLM · Jan 2027 (est.)
Uproleselan — Metastatic Non Small Cell Lung Cancer
February 2027
SXTP · Feb 2027 (est.)
Tafenoquine — Chronic Babesiosis
TVRD · Feb 2027 (est.)
TTI-101 — Hepatocellular Carcinoma
ABCL · Feb 2027 (est.)
LY3819253 — Vasomotor Symptoms Associated With Menopause
AMLX · Feb 2027 (est.)
AMX0035 — ALS
SNDX · Feb 2027 (est.)
Revumenib — Acute Myeloid Leukemias
NBIX · Feb 2027 (est.)
NBI-1065845 — Tardive Dyskinesia
MRK · Feb 2027 (est.)
Pembrolizumab — Triple Negative Breast Cancer
ENLV · Feb 2027 (est.)
Allocetra — Primary Knee Osteoarthritis
GERN · Feb 2027 (est.)
Imetelstat — Myelofibrosis
GNLX · Feb 2027 (est.)
olvimulogene nanivacirepvec — Advanced Non-squamous Non-small-cell Lung Cancer
IRON · Feb 2027 (est.)
DISC-1459 — Polycythemia Vera (PV)
KOD · Feb 2027 (est.)
KSI-101 — Macular Edema Secondary to Inflammation
KRYS · Feb 2027 (est.)
KB803 — Lung Cancer, Non-small Cell
KYTX · Feb 2027 (est.)
Standard of Care Treatment — Idiopathic Inflammatory Myopathies
MLTX · Feb 2027 (est.)
Sonelokimab — Arthritis, Psoriatic
OCGN · Feb 2027 (est.)
OCU410ST — Retinitis Pigmentosa
NBIX · Feb 2027 (est.)
NBI-1065845 — Trichotillomania (Hair-Pulling Disorder)
NVCR · Feb 2027 (est.)
Temozolomide — Spinal Metastasis
AZN · Feb 2027 (est.)
R-Chop — Diffuse Large B-Cell Lymphoma
ARDX · Feb 2027 (est.)
Tenapanor — Chronic Idiopathic Constipation (CIC)
SGP · Feb 2027 (est.)
Bimatoprost Implant System — Glaucoma
FBRX · Feb 2027 (est.)
FB102 — Celiac Disease
March 2027
ADCT · Mar 2027 (est.)
Loncastuximab Tesirine — Relapsed or Refractory Large B-cell Lymphoma
SPTX · Mar 2027 (est.)
SPT-300 — Major Depressive Disorder (MDD)
MNKD · Mar 2027 (est.)
Afrezza — Type 1 Diabetes Mellitus
NUVB · Mar 2027 (est.)
safusidenib — Advanced Solid Tumor
OCGN · Mar 2027 (est.)
OCU410ST — Retinitis Pigmentosa
OCUL · Mar 2027 (est.)
Otx-Tki — Non-Proliferative Diabetic Retinopathy
ONC · Mar 2027 (est.)
Zanubrutinib — Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
PCVX · Mar 2027 (est.)
31-valent pneumococcal conjugate vaccine — Pneumococcal Vaccines
PEPG · Mar 2027 (est.)
PGN-EDODM1 — Myotonic Dystrophy 1
PMVP · Mar 2027 (est.)
rezatapopt — TP53 Y220C Mutation
PSTV · Mar 2027 (est.)
Rhenium Liposome Treatment — Ependymoma
STOK · Mar 2027 (est.)
zorevunersen — Dravet Syndrome
SXTP · Mar 2027 (est.)
Tafenoquine — Babesiosis
URGN · Mar 2027 (est.)
UGN-104 — Upper Urinary Tract Urothelial Carcinoma
VSTM · Mar 2027 (est.)
avutometinib — Mesonephric Gynecologic Cancer
AGIO · Mar 2027 (est.)
Mitapivat — Chondrosarcoma
ALC · Mar 2027 (est.)
Vehicle — Ocular Hyperemia
ALGS · Mar 2027 (est.)
ALG-000184 — Chronic Hepatitis B Infection
ALLR · Mar 2027 (est.)
2X-121 — Advanced Ovarian Cancer
AURA · Mar 2027 (est.)
Bel-sar — Non-muscle-invasive Bladder Cancer
IPHA · Mar 2027 (est.)
Monalizumab — Metastatic Cancer
MDGL · Mar 2027 (est.)
Resmetirom — Non-Alcoholic Fatty Liver Disease
IONS · Mar 2027 (est.)
Olezarsen — Severe Hypertriglyceridemia
FDMT · Mar 2027 (est.)
4D-150 IVT — Neovascular (Wet) Age-Related Macular Degeneration
BMRN · Mar 2027 (est.)
Vosoritide — Noonan Syndrome
BPTH · Mar 2027 (est.)
BP1001 in combination with Ventoclax plus decitabine — Acute Myeloid Leukemia, in Relapse
CGEN · Mar 2027 (est.)
COM701 — Ovarian Cancer
CLDX · Mar 2027 (est.)
Barzolvolimab — Mild to Moderate Asthma
COGT · Mar 2027 (est.)
CGT9486 — Intrahepatic Cholangiocarcinoma (Icc)
DNLI · Mar 2027 (est.)
BIIB122 — Parkinson Disease
SNDX · Mar 2027 (est.)
Revumenib — Acute Myeloid Leukemia
FBRX · Mar 2027 (est.)
FB102 — Alopecia Areata
TSHA · Mar 2027 (est.)
TSHA-101 — Infantile GM2 Gangliosidosis (Disorder)
TVTX · Mar 2027 (est.)
Pegtibatinase — Focal Segmental Glomerulosclerosis
RYTM · Mar 2027 (est.)
Setmelanotide — Hypothalamic Obesity
ZLAB · Mar 2027 (est.)
ZL-1109 — Thyroid Eye Disease (TED)
UTHR · Mar 2027 (est.)
CDX-1140 — Ovarian Clear Cell Adenocarcinoma
HELP · Mar 2027 (est.)
CYB003 — Major Depressive Disorder (MDD)
BPTH · Mar 2027 (est.)
BP1001 in combination with Ventoclax plus decitabine — Poliomyelitis
GILD · Mar 2027 (est.)
Sacituzumab Govitecan — HER2-negative Breast Cancer
CLDX · Mar 2027 (est.)
Barzolvolimab — Glioblastoma
CGON · Mar 2027 (est.)
Cretostimogene Grenadenorepvec — High-Risk Non-Muscle-Invasive Bladder Cancer
MSLE · Mar 2027 (est.)
SAT-3247 — Duchenne Muscular Dystrophy
TNGX · Mar 2027 (est.)
Abemaciclib — Non Small Cell Lung Cancer
ALT · Mar 2027 (est.)
Pemvidutide — Alcohol Liver Disease
April 2027
IXHL · Apr 2027 (est.)
IHL-42X Low Dose — Obstructive Sleep Apnea (OSA)
CGTX · Apr 2027 (est.)
Dextromethorphan-Bupropion — Early Alzheimer's Disease
CLYM · Apr 2027 (est.)
Budoprutug — Systemic Lupus Erythematosus
GKOS · Apr 2027 (est.)
GLK-221 — Keratoconus
KOD · Apr 2027 (est.)
KSI-101 — Macular Edema Secondary to Inflammation
KPTI · Apr 2027 (est.)
Selinexor — Multiple Myeloma
KYTX · Apr 2027 (est.)
Standard of Care Treatment — Multiple Sclerosis, Primary Progressive
LONA · Apr 2027 (est.)
Lasofoxifene in combination with abemaciclib — Metastatic Breast Cancer
MNOV · Apr 2027 (est.)
MN-166 — Amyotrophic Lateral Sclerosis
PBLS · Apr 2027 (est.)
FOG-001 — Cancer
NKTX · Apr 2027 (est.)
NKX019 — Lupus Nephritis
SMMT · Apr 2027 (est.)
Ivonescimab — Endometrial Cancer
TLSA · Apr 2027 (est.)
Foralumab Nasal — Multiple System Atrophy
VSTM · Apr 2027 (est.)
avutometinib — Low-Grade Serous Ovarian Cancer
VTVT · Apr 2027 (est.)
Cadisegliatin — Type 1 Diabetes (T1D)
XENE · Apr 2027 (est.)
Azetukalner — Primary Generalized Tonic-Clonic Seizures
CLDX · Apr 2027 (est.)
Barzolvolimab — Malignant Epithelial Neoplasms
TLX · Apr 2027 (est.)
177Lu-TLX591 — Bone Pain
ALNY · Apr 2027 (est.)
ALN-2232 — Obesity
IOVA · Apr 2027 (est.)
Lifileucel plus Pembrolizumab — Bone Sarcoma
IDYA · Apr 2027 (est.)
Darovasertib — Uveal Melanoma
ISRG · Apr 2027 (est.)
filricianine — Ureter Injury
NBTX · Apr 2027 (est.)
NBTXR3 — Radiotherapy
NVS · Apr 2027 (est.)
Iptacopan — Generalized Myasthenia Gravis
REGN · Apr 2027 (est.)
Cemiplimab — Colon Cancer
RLAY · Apr 2027 (est.)
RLY-2608 — PIK3CA Mutation
AIM · Apr 2027 (est.)
Ampligen — Prostate Adenocarcinoma
May 2027
TELO · May 2027 (est.)
Zn-Telomir — Triple-Negative Breast Cancer (TNBC)
TNGX · May 2027 (est.)
S095035 — MTAP-deleted Solid Tumors
VOR · May 2027 (est.)
Telitacicept — Generalized Myasthenia Gravis
VYGR · May 2027 (est.)
VY7523 — Alzheimer's Disease (AD)
XENE · May 2027 (est.)
Azetukalner — Major Depressive Disorder
ZURA · May 2027 (est.)
Tibulizumab — Systemic Sclerosis (SSc)
SPTX · May 2027 (est.)
SPT-300 — Major Depressive Disorder (MDD)
IOVA · May 2027 (est.)
Lifileucel plus Pembrolizumab — Uveal Melanoma
IMVT · May 2027 (est.)
IMVT-1402 — Graves' Disease
BOLT · May 2027 (est.)
BDC-4182 — Gastric Cancer Adenocarcinoma Metastatic
CMPX · May 2027 (est.)
CTX-009 — Metastatic Biliary Tract Cancer
CRNX · May 2027 (est.)
Atumelnant — Congenital Adrenal Hyperplasia
GH · May 2027 (est.)
FOLFIRI+cetuximab — Metastatic Non-small Cell Lung Cancer
SLDB · May 2027 (est.)
SGT-003 — Duchenne Muscular Dystrophy
REGN · May 2027 (est.)
Cemiplimab — Recurrent Ovarian Cancer
REGN · May 2027 (est.)
Cemiplimab — Non-Small Cell Lung Cancer
FDMT · May 2027 (est.)
4D-150 IVT — Choroideremia
MBX · May 2027 (est.)
MBX 2109 — Hypoparathyroidism
ALNY · May 2027 (est.)
ALN-4324 — Type 2 Diabetes Mellitus (T2DM)
OLMA · May 2027 (est.)
Palazestrant — Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)
ZLAB · May 2027 (est.)
ZL-1310 — SCLC
ACRV · May 2027 (est.)
ACR-368 — Endometrial Adenocarcinoma
BIIB · May 2027 (est.)
Felzartamab — Immunoglobulin A Nephropathy (IgAN)
GERN · May 2027 (est.)
Imetelstat — Phase II
RIGL · May 2027 (est.)
Fostamatinib Disodium — Acute Respiratory Distress Syndrome
RVMD · May 2027 (est.)
RMC-6236 — Non-small Cell Lung Cancer (NSCLC)
June 2027
BLLN · Jun 2027 (est.)
5-Fluorouracil — Gastroesophageal Adenocarcinoma
BMEA · Jun 2027 (est.)
icovamenib — Type 2 Diabetes
CRSP · Jun 2027 (est.)
CTX001 — Cardiovascular
BSX · Jun 2027 (est.)
Colchicine — Hepatocellular Carcinoma
CRVS · Jun 2027 (est.)
Soquelitinib — Atopic Dermatitis
EIKN · Jun 2027 (est.)
EIK1001 — Advanced Solid Tumor
VRCA · Jun 2027 (est.)
Part 1: VP-315 3 Day Dosing/Week — Common Warts
VSTM · Jun 2027 (est.)
avutometinib — Pancreatic Ductal Adenocarcinoma (PDAC)
APRE · Jun 2027 (est.)
APR-246 + azacitidine — Advanced Solid Tumor
ARWR · Jun 2027 (est.)
Plozasiran — Alzheimer Disease
ASND · Jun 2027 (est.)
TransCon CNP — Hypoparathyroidism
AVLN · Jun 2027 (est.)
AP01 — Pulmonary Fibrosis
TNGX · Jun 2027 (est.)
TNG462 — PDAC
TARA · Jun 2027 (est.)
Choline Chloride for Injection — Choline Deficiency
KYMR · Jun 2027 (est.)
KT-621 — Atopic Dermatitis
FDMT · Jun 2027 (est.)
4D-150 IVT — Macular Neovascularization Secondary to Age-Related Macular Degeneration
FTH · Jun 2027 (est.)
SNS-101 — Solid Tumor, Adult
IMMP · Jun 2027 (est.)
eftilagimod alfa — Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
INBX · Jun 2027 (est.)
INBRX-106 — Triple Negative Breast Cancer
INKT · Jun 2027 (est.)
agenT-797 — Pneumonia
IONS · Jun 2027 (est.)
Olezarsen — Familial Chylomicronemia Syndrome
IPHA · Jun 2027 (est.)
Monalizumab — Non Small Cell Lung Cancer
IRON · Jun 2027 (est.)
DISC-1459 — Sickle Cell Disease
JAZZ · Jun 2027 (est.)
CPX-351 — Acute Myeloid Leukemia
KPTI · Jun 2027 (est.)
Selinexor — Myelofibrosis
KYTX · Jun 2027 (est.)
Standard of Care Treatment — Rheumatoid Arthritis
SVRA · Jun 2027 (est.)
Molgramostim — Autoimmune Pulmonary Alveolar Proteinosis
LBRX · Jun 2027 (est.)
LB-102 — Schizophrenia
LNTH · Jun 2027 (est.)
PI-2620 — Alzheimer Disease
MANE · Jun 2027 (est.)
VDPHL01 — Androgenetic Alopecia (AGA)
NMRA · Jun 2027 (est.)
NMRA-335140 — Major Depressive Disorder
ORKA · Jun 2027 (est.)
ORKA-001 — Plaque Psoriasis
PHVS · Jun 2027 (est.)
deucrictibant — Hereditary Angioedema
RIGL · Jun 2027 (est.)
Fostamatinib Disodium — Targeted Therapy
RXRX · Jun 2027 (est.)
REC-2282 — Familial Adenomatous Polyposis
SLDB · Jun 2027 (est.)
SGT-003 — Catecholaminergic Polymorphic Ventricular Tachycardia
MIST · Jun 2027 (est.)
Etripamil NS — Paroxysmal Supraventricular Tachycardia
NVS · Jun 2027 (est.)
Remibrutinib — Hidradenitis Suppurativa
SMMT · Jun 2027 (est.)
Ivonescimab — Thymus Carcinoma
BLTE · Jun 2027 (est.)
Tinlarebant — Geographic Atrophy
IMNN · Jun 2027 (est.)
IMNN-001 — Ovarian Cancer
INDP · Jun 2027 (est.)
Decoy20 — Solid Tumor, Adult
LEGN · Jun 2027 (est.)
LCAR-B38M CAR-T Cell — Relapsed/Refractory B-cell Malignancies
MIRM · Jun 2027 (est.)
BJT-778 — Chronic Hepatitis D Infection
PBYI · Jun 2027 (est.)
neratinib — Hormone Receptor Positive HER-2 Negative Breast Cancer
RIGL · Jun 2027 (est.)
Fostamatinib Disodium — Mutant IDH1 Inhibitor Olutasidenib
ACRS · Jun 2027 (est.)
A-101 — Metastatic Pancreatic Ductal Adenocarcinoma
ALNY · Jun 2027 (est.)
ALN-6400 — Von Willebrand Disease (VWD)
July 2027
NBIX · Jul 2027 (est.)
NBI-1065845 — Major Depressive Disorder
BHVN · Jul 2027 (est.)
BHV-1400 — IgA Nephropathy
BPTH · Jul 2027 (est.)
BP1001 in combination with Ventoclax plus decitabine — Solid Tumor, Adult
KPTI · Jul 2027 (est.)
Selinexor — Relapse Multiple Myeloma
KRYS · Jul 2027 (est.)
KB803 — Cancer
KURA · Jul 2027 (est.)
Ziftomenib — KMT2A-rearranged
MESO · Jul 2027 (est.)
Rexlemestrocel-L — Degenerative Disc Disease
NTLA · Jul 2027 (est.)
NTLA-2002 — Neuromuscular Disease
TLX · Jul 2027 (est.)
177Lu-TLX591 — Neoplastic Disease
UTHR · Jul 2027 (est.)
Inhaled Treprostinil — COPD (Chronic Obstructive Pulmonary Disease)
VKTX · Jul 2027 (est.)
VK2735 — Weight Loss
ZVRA · Jul 2027 (est.)
KP415 oral capsule — Combined D,L-2-hydroxyglutaric Aciduria
ALVO · Jul 2027 (est.)
Eylea Hd — Diabetic Macular Edema
ANL · Jul 2027 (est.)
Buparlisib & Paclitaxel — Advanced Solid Tumor (Phase 1)
ARTV · Jul 2027 (est.)
Rituximab — Rheumatoid Arthritis
ONCY · Jul 2027 (est.)
REOLYSIN — Anal Cancer Metastatic
TPST · Jul 2027 (est.)
TPST-1120 — Advanced Liver Cancers
TGTX · Jul 2027 (est.)
Ublituximab — Multiple Sclerosis
BTAI · Jul 2027 (est.)
Sublingual film containing dexmedetomidine — Schizophrenia
MAIA · Jul 2027 (est.)
6-Thio-2'-Deoxyguanosine — Carcinoma, Non-Small -Cell Lung
AMGN · Jul 2027 (est.)
ABP 938 — Neovascular Age-related Macular Degeneration
August 2027
SMMT · Aug 2027 (est.)
Ivonescimab — Advanced Head and Neck Squamous Cell Carcinoma
SUPN · Aug 2027 (est.)
SPN-817 — Focal Onset Seizures
TLX · Aug 2027 (est.)
177Lu-TLX591 — Clear Cell Renal Cell Carcinoma (ccRCC)
TNYA · Aug 2027 (est.)
TN-201 — Hypertrophic Cardiomyopathy
TVTX · Aug 2027 (est.)
Pegtibatinase — Homocystinuria
VRCA · Aug 2027 (est.)
Part 1: VP-315 3 Day Dosing/Week — Common Warts
ZLAB · Aug 2027 (est.)
ZL-1310 — Solid Tumors
ACAD · Aug 2027 (est.)
ACP-204 — Major Depressive Disorder (MDD)
ADCT · Aug 2027 (est.)
Loncastuximab Tesirine — Follicular Lymphoma
ARTV · Aug 2027 (est.)
AB-101 — Lupus Nephritis - WHO Class III
ASND · Aug 2027 (est.)
TransCon CNP — Advanced Solid Tumor
RARE · Aug 2027 (est.)
Triheptanoin — Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
PVLA · Aug 2027 (est.)
QTORIN — Angiokeratomas
NVCR · Aug 2027 (est.)
Temozolomide — Adenocarcinoma of Lung
NBIX · Aug 2027 (est.)
NBI-1065845 — Schizophrenia
BBOT · Aug 2027 (est.)
BBO-11818 — Non-Small Cell Lung Cancer
BHVN · Aug 2027 (est.)
BHV-8000 — Parkinson Disease
CLLS · Aug 2027 (est.)
UCART22 — B-cell Non-Hodgkin Lymphoma (B-NHL)
CLYM · Aug 2027 (est.)
Budoprutug — Immune Thrombocytopenia (ITP)
CRNX · Aug 2027 (est.)
Atumelnant — Carcinoid Syndrome
DFTX · Aug 2027 (est.)
DT120 — Autism Spectrum Disorder
IONS · Aug 2027 (est.)
ION582 — Angelman Syndrome
JNJ · Aug 2027 (est.)
Talquetamab — Multiple Myeloma
KPRX · Aug 2027 (est.)
KIO-301 — Retinitis Pigmentosa
SMMT · Aug 2027 (est.)
Ivonescimab — Biliary Tract Cancer
LCTX · Aug 2027 (est.)
AST-OPC1 — Spinal Cord Injury Cervical
VIR · Aug 2027 (est.)
VIR-5818 — Locally Advanced or Metastatic HER2-Expressing Cancers
VSTM · Aug 2027 (est.)
avutometinib — Thyroid Cancer
ARWR · Aug 2027 (est.)
Plozasiran — Homozygous Familial Hypercholesterolemia
PMVP · Aug 2027 (est.)
rezatapopt — Myelodysplastic Syndrome
NVCR · Aug 2027 (est.)
Temozolomide — Pancreatic Adenocarcinoma
CSLLY · Aug 2027 (est.)
CSL300 — End Stage Kidney Disease (ESKD)
ONCY · Aug 2027 (est.)
REOLYSIN — Ras-mutated Metastatic Colorectal Cancer
RADX · Aug 2027 (est.)
RAD101 — Imaging
ALNY · Aug 2027 (est.)
ALN-4324 — Obese or Overweight Healthy Volunteers
TLX · Aug 2027 (est.)
177Lu-TLX591 — ccRCC
RIGL · Aug 2027 (est.)
Fostamatinib Disodium — Myelodysplastic Syndromes
MIRM · Aug 2027 (est.)
Brelovitug — Chronic Hepatitis D
CRDF · Aug 2027 (est.)
Onvansertib — Small-cell Lung Cancer
BNTX · Aug 2027 (est.)
ONC-392 — Non Small Cell Lung Cancer
CANF · Aug 2027 (est.)
Piclidenoson — Lowe Syndrome
September 2027
ALKS · Sep 2027 (est.)
Olz/Sam — Bipolar I Disorder
BHVN · Sep 2027 (est.)
BHV-1300 — Graves Disease
CHRS · Sep 2027 (est.)
CHS-1420 — Hepatocellular Carcinoma
CLYM · Sep 2027 (est.)
Budoprutug — Systemic Lupus Erthematosus
CORT · Sep 2027 (est.)
Relacorilant — Adenocarcinoma
CSTL · Sep 2027 (est.)
FCX-007 — Dystrophic Epidermolysis Bullosa
CYTK · Sep 2027 (est.)
Omecamtiv Mecarbil — Heart Failure
DFTX · Sep 2027 (est.)
DT120 — Major Depressive Disorder
HUMA · Sep 2027 (est.)
Human Acellular Vessel — Trauma
IMVT · Sep 2027 (est.)
IMVT-1402 — Rheumatoid Arthritis
IOVA · Sep 2027 (est.)
Lifileucel plus Pembrolizumab — Unresectable Melanoma
KARD · Sep 2027 (est.)
danicamtiv — Symptomatic Genetic Dilated Cardiomyopathy
KTTA · Sep 2027 (est.)
PAS-004 — NF1 Mutation
KYTX · Sep 2027 (est.)
Standard of Care Treatment — Myasthenia Gravis
NEO · Sep 2027 (est.)
IO102-IO103 in combination with pembrolizumab — Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
RZLT · Sep 2027 (est.)
Ersodetug — Tumor Hyperinsulinism (Tumor HI)
SMMT · Sep 2027 (est.)
Ivonescimab — Metastatic Esophageal Adenocarcinoma
TLSI · Sep 2027 (est.)
Pembrolizumab — Locally Advanced Pancreatic Adenocarcinoma
UPB · Sep 2027 (est.)
Verekitug — Severe Asthma
XFOR · Sep 2027 (est.)
Mavorixafor — Neutropenia
AGEN · Sep 2027 (est.)
Botensilimab — Metastatic Colorectal Cancer
ARWR · Sep 2027 (est.)
Plozasiran — Obesity
INCY · Sep 2027 (est.)
Corticosteroids — Chronic Graft-versus-host-disease
ACXP · Sep 2027 (est.)
Ibezapolstat — Clostridium Difficile Infection Recurrence
ADPT · Sep 2027 (est.)
Bendamustine — Lymphoma
VIR · Sep 2027 (est.)
VIR-5500 — Hormone-refractory Prostate Cancer
CNTA · Sep 2027 (est.)
cleminorexton — Narcolepsy Type 1
FATE · Sep 2027 (est.)
FT819 — Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)
IVA · Sep 2027 (est.)
IVA337 — NASH - Nonalcoholic Steatohepatitis
MAIA · Sep 2027 (est.)
6-Thio-2'-Deoxyguanosine — Carcinoma, Non-Small-Cell Lung
RNTX · Sep 2027 (est.)
LTI-03 — Idiopathic Pulmonary Fibrosis (IPF)
VNDA · Sep 2027 (est.)
Tradipitant — Motion Sickness
ACTU · Sep 2027 (est.)
ING-41 — Pancreatic Adenocarcinoma
October 2027
CERS · Oct 2027 (est.)
S-303 Treated Red Blood Cells — Transfusion Reaction, Hemolytic
CLYM · Oct 2027 (est.)
Budoprutug — Primary Membranous Nephropathy
CORT · Oct 2027 (est.)
Relacorilant — Metastatic Breast Cancer
EVMN · Oct 2027 (est.)
EVO756 — Migraine
EYPT · Oct 2027 (est.)
EYP-1901 — Diabetic Macular Edema
ICLR · Oct 2027 (est.)
PRX-102 — Fabry Disease
JBIO · Oct 2027 (est.)
JADE101 — Rhematoid Arthritis
LLY · Oct 2027 (est.)
Tirzepatide — Obesity
NBIX · Oct 2027 (est.)
NBI-1065845 — Schizophrenia
NVCR · Oct 2027 (est.)
Temozolomide — Pancreas Cancer
OGN · Oct 2027 (est.)
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5 — Esophagogastric Adenocarcinoma
ONC · Oct 2027 (est.)
Zanubrutinib — Primary Membranous Nephropathy
OPK · Oct 2027 (est.)
CTAP101 — CKD Stage 3
ORKA · Oct 2027 (est.)
ORKA-001 — Plaque Psoriasis
TARS · Oct 2027 (est.)
TP-03 — Lyme Disease
VERU · Oct 2027 (est.)
Enobosarm & Abemaciclib Combo — Obesity & Overweight
AGEN · Oct 2027 (est.)
Balstilimab — Metastatic Prostate Cancer
APVO · Oct 2027 (est.)
ALG.APV-527 — Acute Myeloid Leukemia (AML)
MRK · Oct 2027 (est.)
MK-8527 — Human Immunodeficiency Virus (HIV)
ONC · Oct 2027 (est.)
Tislelizumab — Metastatic Gastric Adenocarcinoma
PBYI · Oct 2027 (est.)
neratinib — Small Cell Lung Cancer
RYTM · Oct 2027 (est.)
Setmelanotide — Obesity Associated With Defects in Leptin-melanocortin Pathway
TFX · Oct 2027 (est.)
Fresh Frozen Plasma — Cervix Cancer
TLX · Oct 2027 (est.)
177Lu-TLX591 — Advanced Cancer
CUE · Oct 2027 (est.)
CUE-101 — Oropharyngeal Squamous Cell Carcinoma
LXRX · Oct 2027 (est.)
Sotagliflozin — Type 1 Diabetes
November 2027
CRNX · Nov 2027 (est.)
Atumelnant — Congenital Adrenal Hyperplasia
CHRS · Nov 2027 (est.)
CHS-1420 — Ovarian Cancer Stage IV
CRIS · Nov 2027 (est.)
chondrocyte-alginate gel suspension — Chronic Lymphocytic Leukemia
CRVS · Nov 2027 (est.)
Soquelitinib — Peripheral T-Cell Lymphoma, Not Otherwise Specified
MPLT · Nov 2027 (est.)
ML-007C-MA — Autism Spectrum Disorder
NBIX · Nov 2027 (est.)
NBI-1065845 — Schizophrenia
ONC · Nov 2027 (est.)
BGB-3111 — B-cell Malignancies
RNAC · Nov 2027 (est.)
Decartes-08 — Antisynthetase Syndrome
RYTM · Nov 2027 (est.)
Setmelanotide — Hypothalamic Obesity
SABS · Nov 2027 (est.)
SAB-142 — Type 1 Diabetes
SYK · Nov 2027 (est.)
Ropivacaine — Breast Cancer
UTHR · Nov 2027 (est.)
Inhaled Treprostinil — Progressive Pulmonary Fibrosis
VERA · Nov 2027 (est.)
Atacicept — pMN
ANRO · Nov 2027 (est.)
ALTO-207 — Treatment-resistant Depression (TRD)
AURA · Nov 2027 (est.)
Bel-sar — Choroidal Melanoma
CGEN · Nov 2027 (est.)
COM701 — Neoplasm
REGN · Nov 2027 (est.)
Cemdisiran — Age-related Macular Degeneration (AMD)
MYGN · Nov 2027 (est.)
Niraparib — Solid Tumor
SRPT · Nov 2027 (est.)
SRP-1005 — Huntington's Disease
ARVN · Nov 2027 (est.)
ARV-471 — KRAS G12D Mutation
CTMX · Nov 2027 (est.)
CX-072 — Solid Tumor, Adult
December 2027
RARE · Dec 2027 (est.)
Triheptanoin — Medium-chain Acyl-CoA Dehydrogenase Deficiency
RNAC · Dec 2027 (est.)
Decartes-08 — Childhood-onset Systemic Lupus Erythematous
AKTS · Dec 2027 (est.)
AKY-1189 — Urothelial Carcinoma Bladder
ASND · Dec 2027 (est.)
TransCon CNP — Achondroplasia
ARWR · Dec 2027 (est.)
Plozasiran — Asthma
ANVS · Dec 2027 (est.)
buntanetap/posiphen — Early Alzheimers Disease
ANTX · Dec 2027 (est.)
Epetraborole — Mycobacterium Abscessus Infection
ALLO · Dec 2027 (est.)
Fludarabine — Large B-cell Lymphoma
ADAG · Dec 2027 (est.)
ADG106 — HER2-negative Breast Cancer
WVE · Dec 2027 (est.)
WVE-210201 — Overweight and Obesity
VSTM · Dec 2027 (est.)
avutometinib — Endometrioid Cancer
TLX · Dec 2027 (est.)
177Lu-TLX591 — Metastatic Castration-resistant Prostate Cancer
TAK · Dec 2027 (est.)
Tislelizumab — Minimal Residual Disease
STRO · Dec 2027 (est.)
Luveltamab tazevibulin — Head and Neck Squamous Cell Carcinoma HNSCC
SMMT · Dec 2027 (est.)
Ivonescimab — Extensive Stage Lung Small Cell Cancer
RVMD · Dec 2027 (est.)
RMC-6236 — NSCLC (Non-small Cell Lung Cancer)
RADX · Dec 2027 (est.)
RAD101 — Castration-Resistant Prostate Cancer (CRPC)
RGNX · Dec 2027 (est.)
Ranibizumab — Diabetic Macular Edema
BCTX · Dec 2027 (est.)
SV-BR-1-GM — Breast Cancer
BPTH · Dec 2027 (est.)
BP1001 in combination with Ventoclax plus decitabine — Acute Myeloid Leukemia (AML)
CANF · Dec 2027 (est.)
Piclidenoson — Plaque Psoriasis
DNLI · Dec 2027 (est.)
Tividenofusp Alfa — Mucopolysaccharidosis II
GOSS · Dec 2027 (est.)
Seralutinib — Pulmonary Arterial Hypertension
IMVT · Dec 2027 (est.)
IMVT-1402 — Generalized Myasthenia Gravis
INTS · Dec 2027 (est.)
INT230-6 — Sarcoma,Soft Tissue
JNJ · Dec 2027 (est.)
Apathy — Parkinson Disease
KURA · Dec 2027 (est.)
Ziftomenib — Gastrointestinal Stromal Tumor (GIST)
KYMR · Dec 2027 (est.)
KT-621 — Eosinophilic Asthma
LEGN · Dec 2027 (est.)
LCAR-B38M CAR-T Cell — Gastric Cancer
LLY · Dec 2027 (est.)
Mirikizumab — Crohn's Disease
MPLT · Dec 2027 (est.)
ML-007C-MA — Psychosis Associated With Alzheimer's Disease
NERV · Dec 2027 (est.)
Roluperidone — Negative Symptoms of Schizophrenia
NTLA · Dec 2027 (est.)
NTLA-2002 — Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
NUVL · Dec 2027 (est.)
Neladalkib — Locally Advanced Solid Tumor
OTLK · Dec 2027 (est.)
bevacizumab — Age-Related Macular Degeneration
PCVX · Dec 2027 (est.)
31-valent pneumococcal conjugate vaccine — Pneumococcal Vaccines
QGEN · Dec 2027 (est.)
INCB161734 — Parkinson Disease
QURE · Dec 2027 (est.)
AMT-191 — Fabry Disease
RIGL · Dec 2027 (est.)
Fostamatinib Disodium — Pancreatic Ductal Adenocarcinoma (PDAC)
PYXS · Dec 2027 (est.)
PYX-201 — Advanced Solid Tumors
SNDX · Dec 2027 (est.)
Revumenib — Acute Myeloid Leukemia
BPTH · Dec 2027 (est.)
BP1001 in combination with Ventoclax plus decitabine — Poliomyelitis
H1 2027 (est.)
SPTX · H1 2027
SPT-300 — Major Depressive Disorder (MDD)
· H1 2027
RPT904 — Ig-E Mediated Food Allergy
H2 2027 (est.)
AVLN · H2 2027
AP01 — Pulmonary Fibrosis
728 upcoming readouts. Source: ClinicalTrials.gov primary-completion estimates (month precision). Readout timing is not a guaranteed announcement date.